Representative before the EPO

Employment test 51 - 200 employees
Company dna barker brettell llp
no operation time available
Headquarter in Birmingham and 7 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

We have observed 188 EP applications Mark Gibson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 08, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12757601

A METHOD OF VACCINATION COMPRISING A HISTONE DEACETYLASE INHIBITOR

IPC classification:
A61K 39/39, A61K 35/76, A61P 37/04
Applicant:
McMaster Industry Liaison Office
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12717460

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

IPC classification:
C07D 471/10, C07D 471/04, C07D 401/06
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12717459

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

IPC classification:
A61K 31/5383, A61K 31/519, A61K 31/4985, A61K 31/437, C07D 498/04, C07D 471/04, A61P 35/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12779785

EXCIPIENT COMPATIBILITY WITH EZATIOSTAT

IPC classification:
A61K 47/38, A61K 38/06, A61K 9/20, A61K 9/16
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12728907

THERAPEUTIC AGENTS FOR REGULATING SERUM PHOSPHORUS

IPC classification:
A61K 38/08, A61P 13/12
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP12746213

N-ACETYL-D-GLUCOSAMINE FOR ENHANCED SPECIFICITY OF STREP A IMMUNOASSAY

IPC classification:
G01N 33/569, G01N 33/558, G01N 33/543
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12753864

COMPOSITIONS AND METHODS FOR SPECIFIC REGULATION OF PYRUVATE DEHYDROGENASE KINASE

IPC classification:
C07K 7/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12756603

NEW AAV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER

IPC classification:
C12N 7/00, C07K 14/005
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION REFUSED
EP12827083

MODULAR, SCALABLE SPILL CONTAINMENT LINING SYSTEM

IPC classification:
E02D 31/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756549

METHOD FOR DETECTING NUCLEOSOMES CONTAINING NUCLEOTIDES

IPC classification:
G01N 33/574
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12762367

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

IPC classification:
G01N 33/68, G01N 33/574
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP12829666

INFECTION ACTIVATED WOUND CARING COMPOSITIONS AND DEVICES

IPC classification:
A61L 15/00, C12Q 1/70
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12830857

INDUSTRIAL WATER PURIFICATION AND DESALINATION

IPC classification:
C02F 103/08, C02F 9/08, C02F 1/66, C02F 1/52, C02F 1/04
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12838765

GERANYLGERANYLACETONE DERIVATIVES

IPC classification:
C07C 49/395, C07C 49/21, C07C 49/203, C07C 49/08
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13190133

Aryl gpr120 receptor agonists and uses thereof

IPC classification:
A61K 31/42, A61K 31/4164, A61K 31/4155, C07D 409/04, C07D 333/16, C07D 307/42, C07D 285/06, C07D 277/24, C07D 263/32, C07D 261/08, C07D 249/06, C07D 233/64, C07D 231/12
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12778672

MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY

IPC classification:
C40B 40/02, C07K 1/107
Agent:
Antonio Maschio, Maschio & Soames IP Limited
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP12791926

CALCIMIMETICS AND METHODS FOR THEIR USE

IPC classification:
A61K 38/08, A61P 19/00, A61P 13/12, A61P 5/20
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP12704978

VASCULAR PLAQUE REMOVAL SYSTEMS, DEVICES, AND METHODS

IPC classification:
A61B 17/221, A61B 17/3207
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12747416

TREATMENT OF SUBMENTAL FAT

IPC classification:
A61P 41/00, A61K 31/56
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP12853218

AMORPHOUS EZATIOSTAT ANSOLVATE

IPC classification:
A61K 31/19, C07C 321/20, A61P 35/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12854847

PHOSPHATE ESTERS OF NORIBOGAINE

IPC classification:
A61K 31/675, A61K 31/65
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12764414

EZATIOSTAT FOR TREATING MULTIPLE MYELOMA

IPC classification:
A61K 38/07, A61K 38/06, A61P 35/02
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859513

SELF-SEALING CATHETERS

IPC classification:
A61M 31/00, A61M 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12810417

2 - (PYRIDIN- 2YL) - 1, 7 -DIAZA- SPIRO [4.4]NONANE- 6 -ONE COMPOUNDS AS VOLTAGE - GATED SODIUM CHANNELS MODULATORS

IPC classification:
A61K 31/407, C07D 487/10, A61P 29/00, A61P 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12816093

DIAGNOSTIC TEST FOR BACTERIAL PATHOGENS USING INTERNAL CONTROL BACTERIAL STRAIN

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP12859455

CROSS-LINKED DEHYDRATED PLACENTAL TISSUE GRAFTS AND METHODS FOR MAKING AND USING THE SAME

IPC classification:
A61F 2/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12810416

2 - (PYRIDIN- 2YL) - 1, 7 -DIAZA-SPIRO [4.4]NONANE- 6 -ONE COMPOUND AS VOLTAGE-GATED SODIUM CHANNELS MODULATOR

IPC classification:
A61K 31/407, C07D 487/10, A61P 29/00, A61P 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12852900

APPARATUS AND METHOD FOR TREATING AQUEOUS SOLUTIONS AND CONTAMINANTS THEREIN

IPC classification:
C02F 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14171739

Genetically modified human natural killer cell lines

IPC classification:
C12N 5/00, C07K 14/705
Agent:
Carpmaels & Ransford LLP
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14169643

Strip ejection system

IPC classification:
A61B 5/00, G01N 33/52, G01N 33/50, G01N 33/487, G01N 33/48, B65H 29/00, B65D 83/08
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14170410

Biomarkers for schizophrenia or other psychotic disorders

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13741387

(1R,4R) 7-OXO-2-AZABICYCLO[2.2.2]OCT-5-ENE AND DERIVATIVES THEREOF

IPC classification:
A61K 31/46, C07D 495/10, C07D 491/10, C07D 451/04
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13740942

SYNTHETIC VOACANGINE

IPC classification:
A61K 31/55, C07D 487/22, C07D 487/18, A61P 25/04
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13741381

INDOLE AND BENZOFURAN FUSED ISOQUINUCLIDENE DERIVATIVES AND PROCESSES FOR PREPARING THEM

IPC classification:
A61K 31/439, C07D 491/147, C07D 487/22, C07D 487/14
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12852862

PLACENTAL TISSUE GRAFTS PRODUCED BY CHEMICAL DEHYDRATION/FREEZE-DRYING AND METHODS FOR MAKING AND USING SAME

IPC classification:
A61K 35/50, A01N 1/00, C12N 5/071
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12856663

TRISUBSTITUTED METHYL ALCOHOLS AND THEIR POLYMERIZABLE DERIVATIVES

IPC classification:
C07C 43/20, C07C 41/58, C07C 41/34
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14155614

Formulations of deoxycholic acid and salts thereof

IPC classification:
A61K 31/575, A61P 3/04
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP13711996

INTERACTIVE TEST DEVICE AND APPARATUS WITH TIMING MECHANISM

IPC classification:
G01N 33/558, G01N 33/52
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13709986

METHOD OF IDENTIFYING VDJ RECOMBINATION PRODUCTS

IPC classification:
C12Q 1/68, C07K 16/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14155911

Cell culture system for determining the sensitizing, allergenic and/or irritating effect of a substance

IPC classification:
G01N 33/50
Agent:
Mark Gibson, Sagittarius IP
Agent:
Christoph Gerspacher, Patentanwälte Ruff, Wilhelm, Beier, Dauster & Partner mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12781802

CANCER TREATMENTS

IPC classification:
A61K 47/48, A61K 39/395, A61K 31/337, A61K 9/51, C07K 16/22, A61P 35/00
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
EXAMINATION IN PROGRESS
EP13717620

CONTAINER AND SYSTEM FOR SAMPLE COLLECTION AND PREPARATION

IPC classification:
B01L 3/00
Applicant:
Northwestern University
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14190691

Casein kinase 1delta (CK1delta) inhibitors

IPC classification:
A61K 31/506, A61K 31/4439, A61K 31/437, A61K 31/00, A61P 25/28
Agent:
Multiple attorneys, Proteome Sciences plc
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP12866861

SYSTEMS AND METHODS FOR MAINTAINING FOODS

IPC classification:
A23L 2/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14184505

Compositions and methods for the prevention and treatment of autoimmune conditions

IPC classification:
A61K 47/48, A61K 39/385, A61K 39/00, G01N 33/564, G01N 33/543, A61P 37/06, A61P 37/00
Applicant:
UTI Limited Partnership
Agent:
Gemma Campabadal i Monfà, Wilson Sonsini Goodrich & Rosati LLP (WSGR)
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13784125

SYSTEM, METHOD, AND COMPUTER ALGORITHM FOR CHARACTERIZATION AND CLASSIFICATION OF ELECTROPHYSIOLOGICAL EVOKED POTENTIALS

IPC classification:
A61B 5/0484
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13725240

CARTRIDGE FOR USE IN AN AUTOMATED SYSTEM FOR ISOLATING AN ANALYTE FROM A SAMPLE, AND METHODS OF USE

IPC classification:
B01L 3/00
Applicant:
Northwestern University
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP13723640

DEVICE FOR ISOLATING AN ANALYTE FROM A SAMPLE, AND METHODS OF USE

IPC classification:
G01N 35/00, B01L 3/00
Applicant:
Northwestern University
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP13793866

METHOD OF DIAGNOSING CANCER COMPRISING DETECTION OF THE METHYLATION SIGNATURE IN THE HTERT PROMOTER

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13725458

TTC8 AS PROGNOSTIC GENE FOR PROGRESSIVE RETINAL ATROPHY IN DOGS

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP13725438

NOVEL COMPOUNDS

IPC classification:
A61K 31/407, C07D 487/10, A61P 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP13725439

NOVEL COMPOUNDS

IPC classification:
A61K 31/438, A61K 31/407, C07D 487/10, C07D 471/10, A61P 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP13745881

BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS

IPC classification:
G01N 33/569
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13829807

MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61K 35/66, A01N 63/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13830009

REINFORCED PLACENTAL TISSUE GRAFTS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61L 27/14, A61F 2/04, A61F 2/02, C12N 5/071
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13759286

METHOD OF DETECTING CHROMOSOMAL ABNORMALITIES

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12747175

LAMINATED TISSUE GRAFTS COMPOSED OF WHARTON'S JELLY AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61F 2/02, A61L 27/50, A61L 27/36
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP15158273

System for fermentation of biomass for the production of ethanol

IPC classification:
C12P 7/10, C12M 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP13838607

SYSTEMS AND METHODS FOR ENZYME DETECTION

IPC classification:
C12N 9/50, C12M 1/40, B82Y 15/00, B01L 3/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13840378

DEVICE AND METHODS FOR SUSTAINED RELEASE OF ANTIPSYCHOTIC MEDICATIONS

IPC classification:
A61K 47/30, A61K 31/519, A61K 9/22, A61K 9/16, A61P 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13840551

MEDICATION DELIVERY, DOSING AND SAFETY DEVICES, SYSTEMS AND KITS, AND METHODS OF USING THE SAME

IPC classification:
A61M 35/00, A61B 19/04
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13843209

CANCER TREATMENTS

IPC classification:
A61K 45/06, A61K 39/395, A61K 31/337, A61K 31/282, B82Y 5/00, A61P 35/00
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
GRANT OF PATENT INTENDED
EP13777330

DIAGNOSTIC METHOD FOR COLORECTAL CANCER

IPC classification:
G01N 33/80, G01N 33/68, G01N 33/66, G01N 33/574, G01N 33/564
Applicant:
Origin Sciences Limited
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13851728

THERAPY FOR CONSTIPATION

IPC classification:
A61K 31/536, A61K 31/365, A61P 1/10
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13855933

CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS

IPC classification:
A61K 38/17, C07K 14/78, A61P 35/04
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP15150984

Genetically modified human natural killer cell lines

IPC classification:
C12N 5/0783, C12N 5/00, C07K 14/705
Agent:
Carpmaels & Ransford LLP
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13854317

CROSS-LINKED COLLAGEN WITH A BOUND ANTIMICROBIAL AGENT

IPC classification:
A61K 38/17, A61K 9/00, A61P 31/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13854737

ELECTROCHEMICAL DETERMINATION OF INFECTION

IPC classification:
A61B 5/145, A61B 5/053, C12Q 1/04
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13857431

TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS

IPC classification:
A61K 38/48, A61K 36/36, A61P 1/14
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13808199

NOVEL METHOD

IPC classification:
C12N 9/02, C12N 5/074, C12N 5/0735
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12890228

SUBSTITUTED NORIBOGAINE

IPC classification:
A61K 31/55
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14702109

DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

IPC classification:
A61K 31/445, C07D 471/04, C07D 403/06, C07D 401/12, C07D 401/06, C07D 277/36, C07D 265/18, C07D 239/54, C07D 231/56, C07D 215/26, C07D 211/88, A61P 35/00
Applicant:
University of Southern California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14740998

METHODS FOR TREATING CARDIAC CONDITIONS

IPC classification:
A61K 35/50, C12N 5/073, A61P 9/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14737866

COMPOSITIONS AND METHODS FOR THE REGULATION OF T REGULATORY CELLS USING TL1A-IG FUSION PROTEIN

IPC classification:
A61P 37/00
Applicant:
University of Miami
Agent:
Mark Gibson, Sagittarius IP
Agent:
Deborah Mary Hart, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14749161

APPARATUS AND METHOD FOR TREATING AQUEOUS SOLUTIONS AND CONTAMINANTS THEREIN

IPC classification:
C02F 1/32
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14704880

SYSTEMS AND METHODS FOR EARLY DISEASE DETECTION AND REAL-TIME DISEASE MONITORING

IPC classification:
G01N 33/50, A61B 5/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12739994

CAMERA ASSEMBLY FOR THE EXTRACTION OF IMAGE DEPTH DISCONTINUITY AND METHOD OF USE

IPC classification:
H04N 5/222, G01B 11/245, G01B 11/24, G01B 11/22, H04N 13/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14775177

NANOPIPETTE DEVICE AND METHOD FOR SUBCELLULAR ANALYSIS

IPC classification:
C12N 5/00, C12M 1/34, G01N 33/53
Applicant:
University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14712530

METHOD OF TREATING INFECTIONS, DISEASES OR DISORDERS OF NAIL UNIT

IPC classification:
A61K 9/00, A61M 37/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14765049

INTRAVENOUS EMULSIONS OF TRIPTOLIDE AS IMMUNOMODULATORS AND ANTICANCER AGENTS I

IPC classification:
A61K 31/57, A61K 31/34, A61K 9/107
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14764291

MOLDED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61K 35/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP13880549

FAST MAGNETIC RESONANCE IMAGING METHOD AND SYSTEM

IPC classification:
G01R 33/56, A61B 5/055
Applicant:
Shenzhen Institute of Advanced Technology - Chinese Academy of Sciences
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14782795

USE OF ANTIBODY-UREASE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES

IPC classification:
C12N 9/96, C07K 16/28, C07K 16/00, A61P 35/00, A61K 47/48, C12N 9/80
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14730083

MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY

IPC classification:
A61K 47/48
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14783309

NDGA POLYMERS AND METAL COMPLEXES THEREOF

IPC classification:
A61P 35/00, A61K 31/05, A61K 31/045, A61K 31/047
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14719823

NOVEL BIOMARKERS

IPC classification:
A61K 38/21, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14725241

MARKER FOR RESPONSE TO ANTIDEPRESSANT THERAPY

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Craig Edward Titmus, Mathys & Squire LLP
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP14763905

TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS

IPC classification:
A61P 31/04, A61P 1/14, A61K 38/48, A23L 33/00, C12N 9/50
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13885866

POLYMER CHELATOR CONJUGATES

IPC classification:
A61P 35/04, A61K 38/17, A61K 31/785
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14742093

STABLE LIQUID FORMULATION OF AMG 416 (VELCALCETIDE)

IPC classification:
A61P 3/14, A61P 5/00, A61K 38/08, A61K 9/08
Applicant:
Amgen Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP14822527

EMBRYO CULTURE METHODS AND MEDIA

IPC classification:
C12N 5/02, C12N 5/0735
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14752914

PREDICTIVE METHOD FOR BONE FRACTURE RISK IN HORSES AND HUMANS

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12701164

PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS

IPC classification:
A61P 3/14, A61K 31/4985, C07D 487/14
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14838972

MICRONIZED PLACENTAL COMPOSITIONS COMPRISING A CHELATOR

IPC classification:
A61K 47/30, A61K 9/16, A61K 35/50
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP15202046

PURIFIED DEOXYCHOLIC ACID AND ITS COSMETIC USE IN THE NON-SURGICAL REMOVAL OF UNDESIRABLE FAT DEPOSITS

IPC classification:
C07J 1/00, C07J 41/00, C07J 13/00, C07J 5/00, A61K 31/575, C07J 9/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14765989

CHROMOSOME CONFORMATION CAPTURE METHOD INCLUDING SELECTION AND ENRICHMENT STEPS

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14843594

COSMETIC USES OF MOLDED PLACENTAL COMPOSITIONS

IPC classification:
A61Q 19/00, A61Q 19/08, A61K 8/72, A61K 8/98
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14845560

METHOD FOR ASSAYING A PROTEASE

IPC classification:
G01N 33/542, C12N 9/74, C12N 9/64, C12N 9/12, G01N 33/58, G01N 33/52, G01N 33/48, C12Q 1/56, C12N 9/50, C12Q 1/37
Applicant:
McMaster University
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP14856528

GENE FOR INDUCTION OF PARTHENOGENESIS, A COMPONENT OF APOMICTIC REPRODUCTION

IPC classification:
A01H 1/00, C12N 5/14, C12N 5/04
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP13896941

ELUTING MATRIX AND USES THEREOF

IPC classification:
A61P 37/00, A61P 3/10, A61K 38/00, A61K 47/42, A61K 9/00
Applicant:
Massachusetts General Hospital
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14821017

METHOD FOR REDUCING ANALYZER VARIABILITY USING A NORMALIZATION TARGET

IPC classification:
G01N 33/558, G01N 21/64, G01N 21/27
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14815838

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15733304

HETEROATOM CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

IPC classification:
C07D 403/12, C07D 241/18, C07D 241/08
Applicant:
University of Southern California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15737660

METHOD FOR INDUCING ANGIOGENESIS

IPC classification:
C12N 5/073, A61K 35/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15702571

BIOMARKERS

IPC classification:
G01N 33/569
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16177700

NOVEL COMPOUNDS

IPC classification:
A61K 31/506, C07D 487/10
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14883031

METHODS FOR ACUTE AND LONG-TERM TREATMENT OF DRUG ADDICTION

IPC classification:
A61P 25/30, A61P 25/04, A61K 31/55
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15758129

THERAPEUTIC USES OF IBOGAINE AND RELATED COMPOUNDS

IPC classification:
A61P 25/34, A61P 25/30, A61K 31/4738, A61K 31/55, A61K 31/404
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15762030

COMPOSITIONS AND METHODS FOR TREATING, INCLUDING PREVENTING, PARVOVIRUS INFECTIONS AND RELATED DISEASES

IPC classification:
C12N 15/00, C12Q 1/68, C12Q 1/70, C07H 21/04, A61K 39/23
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15710233

NOVEL BIOMARKERS

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Craig Edward Titmus, Mathys & Squire LLP
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15717307

WIRELESS SYSTEM FOR NEAR REAL TIME SURVEILLANCE OF DISEASE

IPC classification:
G06F 19/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15773570

METHOD FOR PREPARING AMG 416

IPC classification:
A61K 38/08, C07K 7/00, C07K 1/02
Applicant:
Amgen Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15772723

BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY

IPC classification:
G06F 19/10, C12Q 1/68, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15716570

NAT10 MODULATORS FOR TREATING OR PREVENTING LAMINOPATHIES, AGING AND CANCER

IPC classification:
C07D 285/18, C07D 277/50, A61P 39/00, A61P 17/00, A61P 9/00, A61P 43/00, A61P 35/00, A61K 31/549, A61K 45/06, A61Q 19/08, A61K 31/426
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15785451

A NOVEL AFFINITY MATRIX AND DEVICES FOR ISOLATION AND PURIFICATION OF RNA AND DNA FOR POINT OF CARE MOLECULAR DEVICES

IPC classification:
C12N 15/10
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16192596

D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE

IPC classification:
A61P 1/08, A61K 31/438, C07D 471/10
Applicant:
Millennium Pharmaceuticals, Inc.
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16192999

COMPOSITIONS CONTAINING DEOXYCHOLIC ACID AND C1-3-ALCOHOLS, DIRECTED TO THE PURIFICATION OF DEOXYCHOLIC ACID

IPC classification:
A61P 3/04, A61K 31/575, C07J 9/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15724353

GLYCOLIPID CONTAINING COMPOSITIONS FOR USE IN THE TREATMENT OF TUMOURS

IPC classification:
A61P 35/00, A61K 31/7032
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP16196258

NEW AVV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER

IPC classification:
C12N 7/00, C07K 14/015
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15796851

MICRONIZED WHARTON'S JELLY

IPC classification:
C12N 5/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15728100

DIAGNOSTIC METHOD

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15733015

COMBINATION THERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C AND RADIOTHERAPY

IPC classification:
A61P 35/00, A61K 9/127, A61K 47/50
Applicant:
The University of North Carolina at Chapel Hill
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15809075

TREATING MYELOMAS

IPC classification:
A61P 31/00, A61K 47/50
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15806443

TREATING LYMPHOMAS

IPC classification:
A61K 31/555, A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15731094

NOVEL METHOD

IPC classification:
C12N 15/85, C07K 14/71, C07K 14/705
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15806913

BIOMARKERS AND METHODS FOR MEASURING AND MONITORING AXIAL SPONDYLOARTHRITIS DISEASE ACTIVITY

IPC classification:
G06F 19/28, G06F 19/20, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15812274

SYSTEM FOR ASSESSING GLOBAL WELLNESS

IPC classification:
G01N 33/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14890017

N-SUBSTITUTED NORIBOGAINE PRODRUGS

IPC classification:
A61K 31/55, C07D 487/12, C07D 487/04
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15819525

MICRONIZED WHARTON'S JELLY

IPC classification:
A61L 27/38, A61K 35/50, C12N 5/073
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14896430

PKC-EPSILON INHIBITORS

IPC classification:
A61P 25/00, A61P 25/18, A61K 31/46, A61K 31/4468
Applicant:
University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15774739

COLLAGEN REINFORCED TISSUE GRAFTS

IPC classification:
A61L 15/40, A61L 15/32, A61L 31/04, A61L 27/36, A61L 27/24
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15835106

HEAT CAPTURE, TRANSFER AND RELEASE FOR INDUSTRIAL APPLICATIONS

IPC classification:
F28D 15/06, F28D 15/04, F28D 15/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16203661

PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME

IPC classification:
A61K 9/70, A61L 27/56, A61F 2/02, A61K 35/19, A61K 35/33, A61K 35/50, A61K 35/28, A61L 27/38, A61L 27/36, A01N 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16190682

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

IPC classification:
A61P 5/00, A61P 5/20, A61P 3/14, C07K 7/06, A61K 38/08
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15834396

POLYGALACTURONAN RHAMNOGALACTURONAN1 (PGRG1) COMPOSITION

IPC classification:
A01N 65/00, A61P 13/12, A61P 31/12, A61K 36/00, A61K 36/481
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15767389

MICRONIZED PLACENTAL TISSUE COMPOSITIONS WITH OPTIONAL SEALANT AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61L 26/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15841676

METHOD AND PANEL FOR DETERMINING ACUTE KIDNEY INJURY

IPC classification:
G01N 33/53, G01N 33/48
Applicant:
Yale University
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15844885

STATHERIN PEPTIDES

IPC classification:
C07K 7/08, C07K 7/06, C07K 17/04, C07K 14/47, A61P 19/08, A61P 1/02, A61K 9/10, A61K 38/17, C07K 19/00
Applicant:
University of Western Ontario (UWO)
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15790622

ERYTHROMELALGIA TREATMENT

IPC classification:
A61P 29/00, A61P 25/02, C12Q 1/68, A61K 31/401
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16153978

INTRAOCULAR LENSES WITH QUANTUM DOTS

IPC classification:
A61L 27/50, A61F 2/16
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP15790624

PAROXYSMAL EXTREME PAIN DISORDER TREATMENT

IPC classification:
A61P 29/00, A61P 25/02, C12Q 1/68, A61K 31/401
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15790623

SMALL FIBRE NEUROPATHY TREATMENT

IPC classification:
A61P 25/02, C12Q 1/68, A61K 31/401
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15782205

CARRIER-ANTIBODY COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61P 35/00, C07K 16/32, C07K 16/28, B82Y 5/00, C07K 16/22
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15790220

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP

IPC classification:
A61K 47/50, C07K 7/08
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15816272

FENESTRATION KITS FOR MAKING FENESTRATED PLACENTAL TISSUE ALLOGRAFTS AND METHODS OF USING THE SAME

IPC classification:
A61L 27/60, A61L 27/56, A61L 27/36
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15809878

COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM

IPC classification:
A61P 37/06, A61P 29/00, A61K 36/36, A61J 1/03, A61K 38/48
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15864244

METHODS AND COMPOSITIONS FOR POTENTIATING THE ACTION OF OPIOID ANALGESICS USING IBOGA ALKALOIDS

IPC classification:
A61P 25/36
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15864346

ENERGY EFFICIENT WATER PURIFICATION AND DESALINATION

IPC classification:
C02F 9/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15868632

CARRIER MOLECULE COMPOSITIONS AND RELATED METHODS

IPC classification:
A61K 47/50, A61K 47/42, A61K 9/127, C07K 7/06
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15866475

METHODS AND MATERIALS FOR PREDICTING RESPONSE TO NIRAPARIB

IPC classification:
A61K 31/416, G06F 19/22, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15865346

BIOMARKERS FOR DISTINGUISHING MOOD DISORDERS

IPC classification:
A61K 31/55, G01N 30/72, G01N 27/62, G01N 21/64, G01N 33/68, G01N 33/543, G01N 33/533, G01N 33/53
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15871011

MIXOTROPHIC CHLORELLA-BASED COMPOSITION, AND METHODS OF ITS PREPARATION AND APPLICATION TO PLANTS

IPC classification:
A01N 63/00, A01N 59/04
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15817522

PROCESS FOR PREPARING ALPHA-CARBOXAMIDE PYRROLIDINE DERIVATIVES

IPC classification:
C07D 207/16
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16744053

FLUORESCEIN POLYMER CONJUGATES

IPC classification:
C07D 311/82, A61K 31/20
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16747310

VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES

IPC classification:
A61P 31/12, A61P 35/00, A61K 39/42, A61K 48/00, C12N 15/86, C12N 15/12
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16746027

MOISTURE RESISTANT BIODEGRADABLE COMPOSITION

IPC classification:
B65D 5/42, D21H 21/16
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16707192

NOVEL USE

IPC classification:
C12N 9/12, C12Q 1/68, C12P 19/34
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16711018

COLLAGEN AND MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61L 26/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16748520

ALVEOLAR-LIKE MACROPHAGES AND METHOD OF GENERATING SAME

IPC classification:
C12N 5/10, C12N 5/0789, A61P 11/00, A61K 35/15, C12N 5/0786
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16708304

MEDICAL DEVICES FOR GENERATING HEAT AND METHODS OF TREATMENT USING SAME

IPC classification:
A61F 7/03
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16756263

SINGLE-CELL INTRACELLULAR NANO-PH PROBES

IPC classification:
C12N 5/071, G01N 21/80, G01N 27/49
Applicant:
University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16709516

A PROCESS FOR THE PREPARATION OF NUCLEIC ACID BY MEANS OF 3'-O-AZIDOMETHYL NUCLEOTIDE TRIPHOSPHATE

IPC classification:
C12P 19/34, C07H 21/00, C07H 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16759375

HIGH-EFFICIENCY DESALINATION

IPC classification:
F28F 1/10, F28F 1/00, F28D 15/02
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16762357

METHODS OF TREATING COGNITIVE IMPAIRMENTS OR DYSFUNCTION

IPC classification:
C07K 14/60, A61K 38/25, A61K 38/22, A61K 38/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16765759

METHODS FOR THE TREATMENT OF BLADDER CANCER

IPC classification:
A01N 57/00, A61K 9/127
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16720588

SOLUTION PHASE METHOD FOR PREPARING ETELCALCETIDE

IPC classification:
A61P 3/14, A61P 5/18, A61P 5/20, C07K 7/06, C07K 5/11, C07K 5/083
Applicant:
Amgen Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16716896

THERAPEUTIC COMPOSITIONS AND METHODS OF USE FOR TREATING CANCER

IPC classification:
C12N 9/10, C12N 7/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16783947

SELECTIVE PFKFB4 INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4706, A61K 31/4545, A61K 31/47
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP17188298

MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY

IPC classification:
C07K 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP17188946

FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF

IPC classification:
A61P 3/04, A61K 31/575
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP16811091

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS

IPC classification:
C07D 231/56, A61P 9/10, A61P 27/02, A61K 31/416
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16815334

AZIRIDINE CONTAINING DNA ALKYLATING AGENTS

IPC classification:
A61K 33/42, A61K 31/06, A61K 31/04
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP17190524

MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME

IPC classification:
A61K 8/98, A61P 17/02, A61Q 19/00, A61L 27/36, A61K 35/50
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP16750481

AZIDOMETHYL ETHER DEPROTECTION METHOD

IPC classification:
C07B 41/02, C12P 19/34, C07H 21/00, C07H 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16831146

COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS

IPC classification:
A61K 31/535
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP17202980

LARGE-SCALE WATER PURIFICATION AND DESALINATION

IPC classification:
C02F 1/04, B01D 3/00, F28D 15/02, B01D 3/06, B01D 1/30, B01D 1/26, B01D 3/42
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP16837869

CARRIER-BINDING AGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61K 39/395, A61K 31/337, A61P 35/00, B82Y 5/00, C07K 16/28, C07K 16/22
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16793477

METHODS FOR TREATMENT OF OPIOID DEPENDENCY AND WITHDRAWAL USING NORIBOGAINE

IPC classification:
A61P 25/36, A61K 31/55, A61K 31/407
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16759955

IMMUNOASSAY TEST DEVICE WITH TWO FLUID FLOW PATHS FOR DETECTION AND DIFFERENTIATION OF TWO OR MORE ANALYTES

IPC classification:
G01N 33/558
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16770822

NON-SURGICAL, LOCALIZED DELIVERY OF COMPOSITIONS FOR PLACENTAL GROWTH FACTORS

IPC classification:
A61K 35/50, A61K 47/30, A61K 38/18
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP18154692

MOLDED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61L 27/36, A61K 35/50
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP16784323

COMPOSITIONS COMPRISING A STATIN FOR USE IN METHODS OF ADIPOLYSIS

IPC classification:
A61P 3/06, A61K 45/06, A61K 31/40
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16852551

BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY

IPC classification:
G06F 19/18, G01N 33/536, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16781531

COMPOUNDS AND THERAPEUTIC USES THEREOF

IPC classification:
A61P 35/00, A61K 47/54
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16788348

LIPOSOME COMPOSITION CO-ENCAPSULATING DOXORUBICIN AND A PRODRUG OF MITOMYCIN C

IPC classification:
A61P 35/00, A61K 31/704, A61K 31/407, A61K 9/127, A61K 47/69, A61K 47/54
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16859190

MDCK SUSPENSION CELL LINES IN SERUM-FREE, CHEMICALLY-DEFINED MEDIA FOR VACCINE PRODUCTION

IPC classification:
A61K 39/12, C12N 5/07, C12N 15/06
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16798876

TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF

IPC classification:
A61P 1/00, A61K 31/035
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15868670

GLYCOLIPID COMPOUNDS AND THEIR USES IN THE TREATMENT OF TUMOURS

IPC classification:
A61K 31/7032, C07H 5/06
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made

Please Sign in to use this feature